Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Willem E, Fibbe"'
Autor:
Ruud Das, Rens Roosloot, Melissa van Pel, Koen Schepers, Marijn Driessen, Willem E. Fibbe, Joost Dick de Bruijn, Helene Roelofs
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Cell-based therapies have the potential to become treatment options for many diseases, but efficient scale-out of these therapies has proven to be a major hurdle. Bioreactors can be used to overcome this hurdle, but changing the c
Externí odkaz:
https://doaj.org/article/62daa1df1f634a9aa203429cec3a4b11
Autor:
Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol, Willem E. Fibbe
Publikováno v:
Blood. 141(11):1277-1292
Acute graft-versus-host disease (aGVHD) is an immune cell‒driven, potentially lethal complication of allogeneic hematopoietic stem cell transplantation affecting diverse organs, including the skin, liver, and gastrointestinal (GI) tract. We applied
Autor:
Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen‐Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl‐de Groot, Frederick W. Thielen
Publikováno v:
Leeneman, B, Blommestein, H M, van Dongen-Leunis, A, Algeri, M, Fibbe, W E, Oosten, L, Uyl-de Groot, C A & Thielen, F W 2023, ' Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease ', European Journal of Haematology . https://doi.org/10.1111/ejh.13987
European Journal of Haematology. Wiley-Blackwell Publishing Ltd
European Journal of Haematology. Wiley-Blackwell
European Journal of Haematology. Wiley-Blackwell Publishing Ltd
European Journal of Haematology. Wiley-Blackwell
Background: Evidence regarding health-related quality of life (HRQoL) in patients with steroid-refractory acute graft-versus-host disease (SR-aGvHD) is lacking. Evaluating HRQoL was a secondary objective of the HOVON 113 MSC trial. Here we describe t
Autor:
Niek J Pluijmert, Melina C den Haan, Vanessa L van Zuylen, Paul Steendijk, Hetty C de Boer, Anton J van Zonneveld, Willem E Fibbe, Martin J Schalij, Paul H A Quax, Douwe E Atsma
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217582 (2019)
BackgroundHypercholesterolemia is a major risk factor for ischemic heart disease including acute myocardial infarction. However, long-term effects of hypercholesterolemia in a rodent myocardial ischemia-reperfusion injury model are unknown. Therefore
Externí odkaz:
https://doaj.org/article/5b41e6bc96c544ea857bd84646b3ce45
Autor:
Jesper Kers, Sebastiaan Heidt, Marlies E.J. Reinders, Paula Meij, Dirk Jan A.R. Moes, Helene Roelofs, Aiko P. J. de Vries, Ton J. Rabelink, Cees van Kooten, Koen E. Groeneweg, Johan W. de Fijter, Jonna R. Bank, Dave L. Roelen, Willem E. Fibbe, Frans H.J. Claas, Geertje J Dreyer, Sanne H. Hendriks, Volkert A L Huurman, Melissa van Pel
Publikováno v:
American Journal of Transplantation
American journal of transplantation, 21(9), 3055-3065. Wiley-Blackwell
American Journal of Transplantation, 21(9), 3055-3065. WILEY
American journal of transplantation, 21(9), 3055-3065. Wiley-Blackwell
American Journal of Transplantation, 21(9), 3055-3065. WILEY
After renal transplantation, there is a need for immunosuppressive regimens which effectively prevent allograft rejection, while preserving renal function and minimizing side effects. From this perspective, mesenchymal stromal cell (MSC) therapy is o
Autor:
Joan Isern, Beatriz Martín-Antonio, Roshanak Ghazanfari, Ana M. Martín, Juan A. López, Raquel del Toro, Abel Sánchez-Aguilera, Lorena Arranz, Daniel Martín-Pérez, María Suárez-Lledó, Pedro Marín, Melissa Van Pel, Willem E. Fibbe, Jesús Vázquez, Stefan Scheding, Álvaro Urbano-Ispizúa, Simón Méndez-Ferrer
Publikováno v:
Cell Reports, Vol 3, Iss 5, Pp 1714-1724 (2013)
Strategies for expanding hematopoietic stem cells (HSCs) include coculture with cells that recapitulate their natural microenvironment, such as bone marrow stromal stem/progenitor cells (BMSCs). Plastic-adherent BMSCs may be insufficient to preserve
Externí odkaz:
https://doaj.org/article/ad21aadd3f874fca80991a37cbdb96eb
Autor:
Melina C den Haan, Vanessa-Leigh van Zuylen, Niek J Pluijmert, Cindy I Schutte, Willem E Fibbe, Martin J Schalij, Helene Roelofs, Douwe E Atsma
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152938 (2016)
Human mesenchymal stromal cells (MSCs) have been reported to preserve cardiac function in myocardial infarction (MI) models. Previously, we found a beneficial effect of intramyocardial injection of unstimulated human MSCs (uMSCs) on cardiac function
Externí odkaz:
https://doaj.org/article/dc6cc5517a634a8fb5626ff0e404f174
Autor:
Martin N. J. M. Wasser, Liesbeth E M Oosten, Koen C.M.J. Peeters, Andrea E. van der Meulen-de Jong, P W Jeroen Maljaars, Willem E. Fibbe, Marieke C. Barnhoorn, Dave L. Roelen, Hein W. Verspaget, Daniel W. Hommes, Bert A. Bonsing, Jaap-Jan Zwaginga, Helene Roelofs, C. Janneke van der Woude, Gerard Dijkstra, Ilse Molendijk
Publikováno v:
Journal of Crohn's and Colitis, 14(1), 64-70. OXFORD UNIV PRESS
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 14(1), 64-70. Oxford University Press
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 14(1), 64-70. Oxford University Press
Background and Aims The long-term safety and efficacy of allogeneic bone marrow-derived mesenchymal stromal cell [bmMSC] therapy in perianal Crohn’s disease [CD] fistulas is unknown. We aimed to provide a 4-year clinical evaluation of allogeneic bm
Publikováno v:
Annals of the New York Academy of Sciences
Peripheral blood hematopoietic stem and progenitor cells (HSPCs), mobilized by granulocyte colony‐stimulating factor, are widely used as a source for both autologous and allogeneic stem cell transplantation. The use of mobilized HSPCs has several a
Autor:
Guido Moll, Annika Hult, Lena von Bahr, Jessica J Alm, Nina Heldring, Osama A Hamad, Lillemor Stenbeck-Funke, Stella Larsson, Yuji Teramura, Helene Roelofs, Bo Nilsson, Willem E Fibbe, Martin L Olsson, Katarina Le Blanc
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85040 (2014)
Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens -
Externí odkaz:
https://doaj.org/article/68a1d36a592147c09e8d492f49e178f6